Accept your treatment duties, stay committed to your health goals, and enjoy your accomplishments along the way
The Harrells C-statistic (area under the curve [AUC]) was used to evaluate the applicability of the CV risk prediction model to the semaglutide data (overall, efficacy trials alone, CVOTs alone), with values of 1.0 indicating a perfect predictive performance, 0.91.0 indicating an excellent performance, 0.80.9 indicating a good performance and 0.70.8 indicating a fair performance [32]
Tirzepatide represents a significant step forward in addressing the global challenges of obesity and type 2 diabetes
When you're not constantly battling hunger signals and your body is metabolically primed to use fat for fuel, the entire experience of fat loss transforms
However, most patients experience improvement within 24 weeks as their bodies adapt to the medication